Gene · 7364
Papers2,547
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
761 to 780 of 2,547
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Culture density contributes to hepatic functions of fresh human hepatocytes isolated from chimeric mice with humanized livers: Novel, long-term, functional two-dimensional in vitro tool for developing new drugs. | PLoS One | 2020 | 32915792 | PubTator, text mining | PubMed |
| Microphysiological system modeling of ochratoxin A-associated nephrotoxicity. | Toxicology | 2020 | 32905824 | PubTator, text mining | PubMed |
| The carboxyl-terminal di-lysine motif is essential for catalytic activity of UDP-glucuronosyltransferase 1A9. | Drug Metab Pharmacokinet | 2020 | 32883578 | PubTator, text mining | PubMed |
| EEF1A2 and ERN2 could potentially discriminate metastatic status of mediastinal lymph node in lung adenocarcinomas harboring EGFR 19Del/L858R mutations. | Thorac Cancer | 2020 | 32881299 | PubTator, text mining | PubMed |
| Nonalcoholic Fatty Liver Disease (NAFLD) and Hepatic Cytochrome P450 (CYP) Enzymes. | Pharmaceuticals (Basel) | 2020 | 32872474 | PubTator, text mining | PubMed |
| Potential Interactions of Remdesivir with Pulmonary Drugs: a Covid-19 Perspective. | SN Compr Clin Med | 2020 | 32864571 | PubTator, text mining | PubMed |
| Pharmacogenetics of immunosuppressant drugs: A new aspect for individualized therapy. | World J Transplant | 2020 | 32864355 | PubTator, text mining | PubMed |
| What we already know about rhubarb: a comprehensive review. | Chin Med | 2020 | 32863857 | PubTator, text mining | PubMed |
| Potential Pharmacokinetic Drug-Drug Interactions between Cannabinoids and Drugs Used for Chronic Pain. | Biomed Res Int | 2020 | 32855964 | PubTator, text mining | PubMed |
| Drug Interactions of Psychiatric and COVID-19 Medications. | Basic Clin Neurosci | 2020 | 32855778 | PubTator, text mining | PubMed |
| Epigenetic effects of low-level sodium arsenite exposure on human liver HepaRG cells. | Arch Toxicol | 2020 | 32844245 | PubTator, text mining | PubMed |
| (-)-N-3-Benzylphenobarbital Is Superior to Omeprazole and (+)-N-3-Benzylnirvanol as a CYP2C19 Inhibitor in Suspended Human Hepatocytes. | Drug Metab Dispos | 2020 | 32839278 | PubTator, text mining | PubMed |
| Clinical Utility of CYP2C19 Genotype-Guided Antiplatelet Therapy in Patients at Risk of Adverse Cardiovascular and Cerebrovascular Events: A Review of Emerging Evidence. | Pharmgenomics Pers Med | 2020 | 32821149 | PubTator, text mining | PubMed |
| Clinical Pharmacokinetics of the Novel HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitor Doravirine: An Assessment of the Effect of Patient Characteristics and Drug-Drug Interactions. | Clin Drug Investig | 2020 | 32816220 | PubTator, text mining | PubMed |
| Histone methyltransferase DOT1L coordinates AR and MYC stability in prostate cancer. | Nat Commun | 2020 | 32814769 | PubTator, text mining | PubMed |
| Transcript and protein marker patterns for the identification of steatotic compounds in human HepaRG cells. | Food Chem Toxicol | 2020 | 32810590 | PubTator, text mining | PubMed |
| Expression of genes involved in drug metabolism differs between perfusable 3D liver tissue and conventional 2D-cultured hepatocellular carcinoma cells. | FEBS Open Bio | 2020 | 32794647 | PubTator, text mining | PubMed |
| Pharmacokinetics of antiretroviral and tuberculosis drugs in children with HIV/TB co-infection: a systematic review. | J Antimicrob Chemother | 2020 | 32785712 | PubTator, text mining | PubMed |
| Identification of osalmid metabolic profile and active metabolites with anti-tumor activity in human hepatocellular carcinoma cells. | Biomed Pharmacother | 2020 | 32763815 | PubTator, text mining | PubMed |
| Progress of Bromophenols in Marine Algae from 2011 to 2020: Structure, Bioactivities, and Applications. | Mar Drugs | 2020 | 32759739 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7364/papers?page=39